Kim Edmonds
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Oncology 10
- Cutaneous Melanoma Detection and Management 5
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
-
- Melanoma and MAPK Pathways 5
- Renal and related cancers 3
- Co-authors
- Martin Gore (6 shared papers)James Larkin (10 shared papers)Julia Newton‐Bishop (2 shared papers)Louise Fearfield (2 shared papers)R. K. Sinha (1 shared paper)Eleni Timotheadou (1 shared paper)Kellie A. Charles (1 shared paper)Roger A’Hern (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)Clinical Cancer Research (1 paper)British Journal of Cancer (1 paper)Melanoma Research (1 paper)
- Partner nations
- United KingdomNetherlandsSpain
In The Last Decade
Kim Edmonds
15 papers receiving 548 citations
Peers
Comparison fields: 5 of 80
- Oncology 317
- Immunology 120
- Cancer Research 75
- Molecular Biology 222
- Dermatology 26
Countries citing papers authored by Kim Edmonds
This map shows the geographic impact of Kim Edmonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Edmonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Edmonds more than expected).
Fields of papers citing papers by Kim Edmonds
This network shows the impact of papers produced by Kim Edmonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Edmonds. The network helps show where Kim Edmonds may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim Edmonds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 195 | |
| 2 | 1994 | 106 | |
| 3 | 2012 | 83 | |
| 4 | 2019 | 52 | |
| 5 | 2011 | 34 | |
| 6 | 2010 | 33 | |
| 7 | 2013 | 19 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 10 | |
| 10 | 2015 | 8 | |
| 11 | 2010 | 3 | |
| 12 | 2017 | 2 | |
| 13 | 2012 | 1 | |
| 14 | 2012 | 1 | |
| 15 | 2011 | 1 | |
| 16 | CAPTURE: Cancer and COVID-19 antiviral immune monitoring study | 2020 | 0 |
About Kim Edmonds
Kim Edmonds is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Nephrology and Infectious Diseases, having authored 16 papers that have together received 560 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (5 papers), Renal cell carcinoma treatment (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Renal Diseases and Glomerulopathies (3 papers), Renal and related cancers (3 papers), Economic and Financial Impacts of Cancer (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (317 citations), Immunology (120 citations), Cancer Research (75 citations), Molecular Biology (222 citations) and Dermatology (26 citations). Kim Edmonds has collaborated with scholars based in United Kingdom, Netherlands and Spain. Frequent co-authors include Martin Gore, James Larkin, Julia Newton‐Bishop, Louise Fearfield, R. K. Sinha, Eleni Timotheadou, Kellie A. Charles, Roger A’Hern, Ningfeng Fiona Li and Michelle Harrison. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, British Journal of Cancer and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.